Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem
β Scribed by William E. Boden; Muriel Vray; Evelyne Eschwege; Delphine Lauret; Rudy Scheldewaert
- Book ID
- 112065547
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 706 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0160-9289
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of two new sustained-release (SR) products of diltiazem, Dilapress 120 mg tablets and Dilapress 240 mg tablets, was analysed and characterized in three different studies, in comparison to the following diltiazem SR formulations: Cardizem Retard, Cardizem SR, and Cardizem CD. Dil
The aim of this multicentre randomised double blind study was to compare the efficacy and safety of the 200-300 mg sustained release diltiazem formulation administered once daily (200-300 SR) with standard diltiazem (D) given three or four times daily to patients with stable angina. Patients aged 59